We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KRNY:NASDAQKearny Financial Analysis

Data as of 2026-04-13 - not real-time

$8.04

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kearny Financial is trading at $8.04, comfortably above its 20‑day ($7.53), 50‑day ($7.73) and 200‑day ($7.03) simple moving averages, and the MACD histogram is positive, signaling short‑term bullish momentum. The RSI sits at 64, indicating strength without being overbought, while the stock sits near its technical resistance of $8.21 and above the identified support of $6.92. Volume has been slipping, and 30‑day volatility is elevated at roughly 23%, but the beta below 1 (≈0.87) suggests lower sensitivity to market swings, and the market sentiment index is in “Extreme Greed” territory, hinting at favorable investor appetite.
Fundamentally, KRNY posted 15% revenue growth and maintains healthy operating (31%) and profit (20%) margins, yet its ROE (4.3%) and ROA (0.4%) are modest. Valuation looks attractive: the trailing PE of 15.5 is below the industry average of 17.4, forward PE drops to 9.3, and the price‑to‑book ratio is only 0.67. The dividend yield of 5.5% is generous but the payout ratio of 84% raises sustainability questions given the $1.1 B debt load versus $154 M cash. Overall, the stock appears undervalued with decent growth prospects, but the high dividend payout and debt level temper the upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above all major SMAs
  • High dividend yield attracting income investors
  • Decreasing volume and elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued forward PE of 9.3 versus industry peers
  • 15% revenue growth and strong operating margins
  • Potential upside toward target price around $8.5

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield but high payout ratio
  • Solid cash flow generation offset by sizable debt
  • Stable position in the regional banking sector with moderate regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth15.00%
Profit Margin19.84%
P/E Ratio15.5
ROE4.31%
ROA0.42%
P/B Ratio0.7
Op. Cash Flow$40.7M
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI64.4
Support$6.92
Resistance$8.21
MA 20$7.53
MA 50$7.73
MA 200$7.03
MACDBullish
VolumeDecreasing
Fear & Greed Index87.29

Valuation

Target Price$8.50
Upside/Downside5.72%
GradeUndervalued
TypeBlend
Dividend Yield5.48%

Risk Assessment

Beta0.87
Volatility23.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.